MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BVS — Bioventus Inc. Class A Common Stock
NasdaqBioventus Inc. Class A Common Stock
$13.13
-0.32(-2.38%)
- O
- 13.52
- H
- 13.52
- L
- 13.02
- V
- 362.36K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About BVS
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateFeb 11, 2021
Employees950
Stock ExchangeNasdaq
Ticker SymbolBVS
Websitehttps://www.bioventus.com
Key Financial Statistics
| Market Cap | $943.29M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $6.37 - $15.89 |
| 52-Week Avg Volume | 475.7K |
| VWAP | $13.18 |
| Transactions | 6,775 |
| Total Recorded Bars | 1,417 days |